Must Read Rumors

Prince William says he would run a marathon, Kate Middleton sweetly teases him

The Duchess of Cambridge, née Kate Middleton, proves once more that she never misses a chance to tease her husband.

Kate Middleton, Prince William and Prince Harry join forces for mental health campaign

The Duke and Duchess of Cambridge, née Kate Middleton, as well as Prince Harry are once again committed to their cause of raising awareness for mental health issues.

Kate Middleton and Prince William announce they’re moving to London

The news of their return to London was announced in a press release by Kensington Palace.

Kate Middleton, Prince William and Prince Harry set to be part of mental health documentary

The royal trio will reportedly take part in a mental health documentary for their mental health campaign.

Kate Middleton will visit EACH hospice at Quidenham

The Duchess of Cambridge, née Kate Middleton, is set to visit East Anglia’s Children’s Quidenham hospice for the first time this month.

Prince William says he would run a marathon, Kate Middleton sweetly teases him
Kate Middleton, Prince William and Prince Harry join forces for mental health campaign
Kate Middleton and Prince William announce they’re moving to London
Kate Middleton, Prince William and Prince Harry set to be part of mental health documentary
Kate Middleton will visit EACH hospice at Quidenham

A new plan for a drug against HIV

by Julia
August 22, 2011 at 1:12 am

A new drug that causes HIV to mutate could eventually entirely eliminate the virus in people suffering from it.

The discovery of a drug to cure HIV is a large-scale business. Currently, the market for HIV drugs has reached $ 14 billion, which means $ 600,000 to treat a single patient.

These drugs are designed to suppress and prevent virus propagation, but have many disadvantages, including cost, side effects and that patients depend on them for life.

Koronis Pharmaceuticals, a biotechnology company, has found a possible solution with KP-1461, a new drug that causes mutations in cells affected by HIV. If it will work, patients could get off the drug and recover from AIDS.

KP-1461 uses a new mechanism, called Viral Decay Acceleration T, to insert itself into the viral genome and accelerate the frequency of mutations until the virus collapses.

“If you think of HIV as a house made of two by fours, and the genetic backbone of the virus as the foundation of that house, [the drug mechanism] replaces the two by fours with toothpicks, and eventually the house comes crashing down,” said Dr. Mark G. Fromhold, VP of Manufacturing and Business Development at Koronis.

Until now, the company has successfully tested the drug in the laboratory. testing patients will be much harder but it could be a breakthrough dicovery.

The downside is that patients will have to take the medication for a long time. In the second stage of tests, Koronis will use a combination of therapies and will measure the exact time that the healing of the patients takes. The company wants to raise $ 15 million from business partners for further study.

Filled under: ,

What do you think? What is your gossip?

The rules: Keep it clean, stay on the subject and use English only - or we may delete your comment. If you see inappropriate language email us. Read our Terms and Conditions